Covered recipient · General Payments record
LINDSEY MORGAN TILLERY
Eye and Vision Services Providers Optometrist
General Payments · PY2023–2024
$1,098.24
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $718.75 | 8 |
| Entertainment | $214.84 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| OPTOS, INC. | $214.84 | 1 |
| Dompe US, Inc. | $150.00 | 1 |
| Alcon Laboratories Inc | $144.01 | 1 |
| BIOTISSUE HOLDINGS INC. | $110.49 | 1 |
| CooperVision Inc. | $99.46 | 1 |
| Astellas Pharma Global Development | $92.97 | 1 |
| Tarsus Pharmaceuticals, Inc. | $92.69 | 2 |
| Genentech USA, Inc. | $29.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alcon Vision LLC | $144.01 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110720622 | CMS |
| Astellas Pharma Global Development | $92.97 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132965799 | CMS |
| BIOTISSUE HOLDINGS INC. | $110.49 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148768466 | CMS |
| CooperVision Inc. | $99.46 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145506360 | CMS |
| Dompe US, Inc. | $150.00 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151409655 | CMS |
| Genentech USA, Inc. | $29.13 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133054791 | CMS |
| Optos, Inc. | $214.84 | 02/16/2024 | Entertainment | Undisputed | 01/23/2026 | 1141505776 | CMS |
| Tarsus Pharmaceuticals, Inc. | $57.62 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139136902 | CMS |
| Tarsus Pharmaceuticals, Inc. | $35.07 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139136904 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.